RespireRx Pharmaceuticals Inc. to Present in June 2021 Access China Biotech Virtual Investor Conference

NEXT STORY
A Comprehensive Analysis of 18+ Key Companies Strengthening Chronic Spontaneous Urticaria Pipeline | Insights by DelveInsight
PREV STORY
Kiniksa Announces Issuance of U.S. Patent for Treatment of Recurrent Pericarditis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE “TRANSPARENCY LAW”)

REGULATED INFORMATION GHENT, Belgium, 22 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] ...

author_avatar
NASDAQ Market News

TiGenix présente ses résultats de l’an 2017

author_avatar
NASDAQ Market News

Novaseek Research and CoxHealth Launch Partnership to Advance Biomedical and Clinical Research

author_avatar
NASDAQ Market News